40552511000001108: Cabergoline 500microgram tablets (CST Pharma Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Cabergoline 500microgram tablets (CST Pharma Ltd)
\UK product\Virtual medicinal product\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)
\UK product\Virtual therapeutic moiety\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)
\UK product\Virtual therapeutic moiety\Cabergoline\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing cabergoline\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing cabergoline\Cabergoline\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing cabergoline\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing cabergoline\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing cabergoline\Cabergoline\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing cabergoline\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing cabergoline\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing cabergoline\Cabergoline\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing cabergoline\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Cabergoline 500microgram tablets (CST Pharma Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Mar 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2029071000001113 Cabergoline 500microgram tablets (CST Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2029081000001110 Cabergoline 500microgram tablets (CST Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cabergoline 500microgram tablets (CST Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel import	true	Inferred relationship	Existential restriction modifier
Cabergoline 500microgram tablets (CST Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Cabergoline 500microgram tablets (CST Pharma Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Cabergoline 500microgram tablets (CST Pharma Ltd)	Is a	Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Cabergoline 500microgram tablets (CST Pharma Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Cabergoline 500microgram tablets (CST Pharma Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Cabergoline 500microgram tablets (CST Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Cabergoline 500microgram tablets (CST Pharma Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Cabergoline 500microgram tablets (CST Pharma Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Cabergoline 500microgram tablets (CST Pharma Ltd)	Has specific active ingredient	Cabergoline	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cabergoline 500microgram tablets (CST Pharma Ltd) 8 tablet	Has AMP	True	Cabergoline 500microgram tablets (CST Pharma Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2029071000001113	Cabergoline 500microgram tablets (CST Pharma Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2029081000001110	Cabergoline 500microgram tablets (CST Pharma Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module